文献速递青光眼眼底病与葡萄膜炎

青光眼基因修饰动物模型的研究进展及其在药物重定位中的作用

Recent advances in genetically modified animal models of glaucoma and their roles in drug repositioning.
PubMed 文献 · Br J Ophthalmol · 2018-10-26

该综述总结多种青光眼基因修饰动物模型(如GLAST敲除小鼠、EAAC1敲除小鼠、OPTN E50K敲入小鼠、DBA/2J小鼠及实验诱导模型)的优缺点,指出当前青光眼药物治疗限于降眼压滴眼液,而眼压外因素参与发病尤其正常眼压性青光眼,这些模型有助于阐明发病机制和识别治疗靶点,并汇总利用现有药物进行视网膜保护的基础研究。

要点

  • 当前青光眼药物治疗仅限降眼压滴眼液,但眼压外因素参与发病。
  • 多种基因修饰和实验诱导动物模型各仅代表青光眼部分方面。
  • 这些模型用于阐明发病机制、识别靶点及现有药物视网膜保护研究。

核心结论

  • 青光眼基因修饰动物模型有助于阐明发病机制和识别治疗靶点,但每个模型仅代表疾病部分方面。
  • 现有药物在视网膜保护方面的基础研究是药物重定位的方向之一。

研究设计与样本

  • 综述总结了多种青光眼动物模型,包括GLAST敲除小鼠、EAAC1敲除小鼠、OPTN E50K敲入小鼠、DBA/2J小鼠和实验诱导模型。

主要发现

  • 除眼压外,多种因素参与青光眼发病,尤其在正常眼压性青光眼亚型中。
  • 各种动物模型对阐明发病机制和识别潜在治疗靶点非常有用。
  • 每个模型仅代表青光眼的部分方面,而非整个疾病。

临床怎么用

  • 眼科医生可参考这些模型理解青光眼发病机制及评估现有药物视网膜保护的临床前证据。

局限性

  • 每个动物模型仅代表青光眼的部分方面,不能完全模拟人类疾病全貌。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glaucoma is one of the leading causes of vision loss in the world. Currently, pharmacological intervention for glaucoma therapy is limited to eye drops that reduce intraocular pressure (IOP). Recent studies have shown that various factors as well as IOP are involved in the pathogenesis of glaucoma, especially in the subtype of normal tension glaucoma. To date, various animal models of glaucoma have been established, including glutamate/aspartate transporter knockout (KO) mice, excitatory amino acid carrier 1 KO mice, optineurin E50K knock-in mice, DBA/2J mice and experimentally induced models. These animal models are very useful for elucidating the pathogenesis of glaucoma and for identifying potential therapeutic targets. However, each model represents only some aspects of glaucoma, never the whole disease. This review will summarise the benefits and limitations of using disease models of glaucoma and recent basic research in retinal protection using existing drugs.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Harada C, Kimura A, Guo X, et al. Recent advances in genetically modified animal models of glaucoma and their roles in drug repositioning. Br J Ophthalmol. 2018. PMID: 30366949. doi:10.1136/bjophthalmol-2018-312724

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。